Investigating raised creatine kinase
Measure creatine kinase if a patient on statin therapy develops muscle pain and warrant investigation for underlying secondary causes including endocrine, autoimmune, and genetic disorders.
Abstract
A 76 year old man with hypercholesterolaemia is referred to the lipid clinic because of persistently raised creatine kinase activity of 1000 IU/L or above (reference range 40-320 IU/L) after trying multiple statins. He describes no significant myalgia but had some proximal muscle weakness, which is demonstrated when he stands up from a seated position and when walking upstairs. Creatine kinase (known previously as creatine phosphokinase or CPK) is distinct from creatinine and is a biomarker of muscle damage. The reference range for normal creatine kinase is 40‐320 IU/L for men and 25‐200 IU/L for women, though this may vary across laboratories and assays. Creatine kinase levels are dependent on age, sex, and muscle mass: the upper limit of normal (ULN) for men is higher than in women, and ageing is associated with reduced muscle mass, so minor increases in creatine kinase may indicate a greater extent of muscle damage in older adults.1 Pathologies involving muscle include myalgia (muscle pain with no creatine kinase rise), myopathy (muscle pain with creatine kinase rise), and rhabdomyolysis (muscle pain, weakness, and/or swelling with myoglobinuria and elevated creatine kinase). Creatine kinase can also be elevated without any muscle symptoms.2 Moreover, no clear correlation exists between creatine kinase activity and the extent of actual muscle injury. That said, creatine kinase >5000 IU/L (10-50 times the upper limit of normal) should prompt consideration of rhabdomyolysis. Most cases of raised creatine kinase can …